{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:19:17Z","timestamp":1787768357776,"version":"build-2784847793"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Lipoprotein(a) [Lp(a)] is a low-density lipoprotein-like particle covalently bound to apolipoprotein(a) and encoded by the\n                      <jats:italic>LPA<\/jats:italic>\n                      gene. Elevated plasma levels of Lp(a) are a well-established, independent, and causal risk factor for cardiovascular disease. While the epidemiology of Lp(a) has been extensively mapped in non- African populations, the burden and distribution of Lp(a) in African populations remain under-characterized despite its unique genetic, phenotypic, ethnolinguistic and ancestral diversity. The primary objective was to synthesize existing literature to determine the prevalence and distribution of elevated Lp(a) levels in apparently healthy African individuals residing on the African continent.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review included observational studies (cross-sectional, cohort, and case-control) involving apparently healthy adults (\u226518 years) in Africa. The review systematically searched PubMed\/MEDLINE, Embase, Scopus, African Journals Online, and Google Scholar without language or date restrictions to capture the full breadth of historical and contemporary data. Data were extracted using a standardized form capturing study characteristics, population demographics, assay methods and quantitative outcomes. Methodological quality was assessed using the Newcastle-Ottawa Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 17 studies met the inclusion criteria, representing populations from West Africa (Nigeria, Ghana) Central Africa (Cameroon), Southern Africa (South Africa, Zimbabwe), and North Africa (Morocco, Tunisia). Studies in Ghana reported prevalence rates of elevated Lp(a) (&gt;30 mg\/dL) between 30\u201361%. Lp(a) mean levels ranged from 12.7 mg\/dL to 54.5 mg\/dL depending on the cohort and assay used. Females exhibited higher Lp(a) levels than males across most African cohorts. Clinically, elevated Lp(a) was associated with hypertension, type 2 diabetes mellitus, ischemic stroke, myocardial infarction and anti-retroviral drug use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated Lp(a) is a common, genetically determined trait in Africa rather than a rare dyslipidemia. Far from being a benign variant, it acts as a significant amplifier of cardiovascular risk, particularly in the presence of rising incident rates of hypertension and diabetes. Addressing this burden requires the adoption of standardized, isoform-independent assays and the development of population-specific risk thresholds to guide targeted preventive cardiovascular care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0356490","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:32:43Z","timestamp":1787765563000},"page":"e0356490","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The burden of Lipoprotein(a) [Lp(a)] in Africa: A systematic review"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8895-2000","authenticated-orcid":true,"given":"Lambert Tetteh","family":"Appiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence Koryo","family":"Akumiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3161-9389","authenticated-orcid":true,"given":"Jacob Solomon","family":"Idan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon Manu","family":"Amponsah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5941-9733","authenticated-orcid":true,"given":"Solomon","family":"Gyabaah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit Agyeiwaah","family":"Baah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3201-1006","authenticated-orcid":true,"given":"Frederick Kwarteng","family":"Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-8805","authenticated-orcid":true,"given":"Benedict Kusi","family":"Ampofo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Winfred","family":"Eshun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladotun Victor","family":"Olalusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert-Jan","family":"van den Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Agyemang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"pone.0356490.ref001","article-title":"The Year in Cardiovascular Disease - The Year of Lipoprotein(a) \u2013 Research Advances and New Findings","author":"B Sosnowska","year":"2025","journal-title":"Arch Med Sci"},{"issue":"1","key":"pone.0356490.ref002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5830\/CVJA-2021-001","article-title":"Ethopia Country Report PASCAR and WHF Cardiovascular Diseases Scorecard project","volume":"32","author":"D Yadeta","year":"2021","journal-title":"Cardiovasc J Afr"},{"key":"pone.0356490.ref003","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.athplu.2025.05.003","article-title":"Proposed lipidology and preventive cardiology research priorities in Africa; Results of a Delphi survey","volume":"61","author":"ARM Lyons","year":"2025","journal-title":"Atheroscler Plus"},{"issue":"22","key":"pone.0356490.ref004","first-page":"2167","article-title":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023","volume":"86","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"pone.0356490.ref005","doi-asserted-by":"crossref","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association","volume":"42","author":"G Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"pone.0356490.ref006","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jacasi.2025.04.012","article-title":"Cardiovascular Implications of Lipoprotein(a) and its Genetic Variants: A Critical Review From the Middle East","volume":"5","author":"A El-Menyar","year":"2025","journal-title":"JACC Asia"},{"issue":"11","key":"pone.0356490.ref007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294250","article-title":"Burden of elevated lipoprotein(a) among patients with atherosclerotic cardiovascular disease: Evidence from a systematic literature review and feasibility assessment of meta-analysis","volume":"18","author":"P Orfanos","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"pone.0356490.ref008","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MOL.0000000000000753","article-title":"The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk","volume":"32","author":"G Reyes-Soffer","year":"2021","journal-title":"Curr Opin Lipidol"},{"issue":"10","key":"pone.0356490.ref009","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"M Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"pone.0356490.ref010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"AC Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"pone.0356490.ref011","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"M Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"6","key":"pone.0356490.ref012","first-page":"670","article-title":"First WHO\/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B","volume":"42","author":"International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Working Group for Lipoprotein(a) Assay Standardization","year":"2004","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"pone.0356490.ref013","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10741-021-10160-3","article-title":"A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at risk of heart failure","volume":"27","author":"TA Nyawo","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"6","key":"pone.0356490.ref014","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacl.2014.08.003","article-title":"Lipoprotein(a) mass: a massively misunderstood metric","volume":"8","author":"JP McConnell","year":"2014","journal-title":"J Clin Lipidol"},{"key":"pone.0356490.ref015","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"M Campbell","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"pone.0356490.ref016","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.aje.a116517","article-title":"Serum lipoprotein(a) levels in racially different populations","volume":"136","author":"C Cobbaert","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"2","key":"pone.0356490.ref017","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1098-2272(1997)14:2<157::AID-GEPI5>3.0.CO;2-4","article-title":"Serum distribution of lipoprotein(a) in African Americans and Nigerians: potential evidence for a genotype-environmental effect","volume":"14","author":"CN Rotimi","year":"1997","journal-title":"Genet Epidemiol"},{"issue":"1","key":"pone.0356490.ref018","first-page":"17","article-title":"Lipoprotein(a) concentrations in a black population in Nigeria","volume":"50","author":"RW Evans","year":"1997","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"pone.0356490.ref019","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1139\/H07-186","article-title":"Plasma lipoprotein (a), homocysteine, and other cardiovascular disease (CVD) risk factors in Nigerians with CVD","volume":"33","author":"MO Ebesunun","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"pone.0356490.ref020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1758-5996-2-51","article-title":"Lipoprotein (a) and some other cardiovascular risk factors in patients with type 2 diabetes mellitus","volume":"2","author":"AO Ogbera","year":"2010","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"pone.0356490.ref021","first-page":"2041","article-title":"Evaluation of serum levels of lipoprotein-A and uric acid and their correlation in hypertensive patients in Delta State, Nigeria","volume":"28","author":"AO Eguvbe","year":"2024","journal-title":"J Appl Sci Environ Manag"},{"issue":"1","key":"pone.0356490.ref022","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5334\/gh.850","article-title":"Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT)","volume":"15","author":"LT Appiah","year":"2020","journal-title":"Glob Heart"},{"key":"pone.0356490.ref023","doi-asserted-by":"crossref","first-page":"122839","DOI":"10.1016\/j.jns.2023.122839","article-title":"Frequency & factors associated with elevated lipoprotein-a among Ghanaian stroke survivors","volume":"456","author":"S Gyabaah","year":"2024","journal-title":"J Neurol Sci"},{"issue":"24","key":"pone.0356490.ref024","article-title":"Cardiometabolic Risk Factors and Preclinical Target Organ Damage Among Adults in Ghana: Findings From a National Study","volume":"9","author":"J Li","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"pone.0356490.ref025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0895-4356(97)00129-7","article-title":"Serum LP(a) levels in African aboriginal Pygmies and Bantus, compared with Caucasian and Asian population samples","volume":"50","author":"C Cobbaert","year":"1997","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"pone.0356490.ref026","first-page":"1009","article-title":"Lipoprotein (a) levels in a black South African population","volume":"88","author":"ME Carstens","year":"1998","journal-title":"S Afr Med J"},{"issue":"3","key":"pone.0356490.ref027","first-page":"120","article-title":"The effect of different apo(a) isoforms on plasminogen activation in black South African subjects","volume":"14","author":"SR Choma","year":"2003","journal-title":"Cardiovasc J S Afr"},{"key":"pone.0356490.ref028","first-page":"10","article-title":"Lipoprotein(a) levels and fibrin clot properties in a black South African population: The PHURE study","volume":"234","author":"D Bruwer","year":"2024","journal-title":"Thromb Res"},{"key":"pone.0356490.ref029","first-page":"83","article-title":"Lipoprotein(a) concentrations and apolipoprotein(a) isoform distribution in a Zimbabwean population","volume":"48","author":"N Dube","year":"2002","journal-title":"Cent Afr J Med"},{"issue":"5","key":"pone.0356490.ref030","first-page":"477","article-title":"Lipoprotein (a) as a risk factor for coronary artery disease in women and elderly patients","volume":"55","author":"S Fellat","year":"1997","journal-title":"Ann Biol Clin (Paris)"},{"issue":"5","key":"pone.0356490.ref031","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1056-8727(03)00075-8","article-title":"Lipids and lipoprotein(a) concentrations in Tunisian type 2 diabetic patients; Relationship to glycemic control and coronary heart disease","volume":"18","author":"M Smaoui","year":"2004","journal-title":"J Diabetes Complications"},{"issue":"12","key":"pone.0356490.ref032","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups","volume":"139","author":"G Par\u00e9","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"pone.0356490.ref033","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s42003-025-08020-z","article-title":"Moroccan genome project: genomic insight into a North African population","volume":"8","author":"E El Fahime","year":"2025","journal-title":"Commun Biol"},{"issue":"1","key":"pone.0356490.ref034","article-title":"Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans","volume":"6","author":"RC Deo","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"pone.0356490.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41569-021-00644-y","article-title":"Cardiovascular health and disease in migrant populations: a call to action","volume":"19","author":"C Agyemang","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"pone.0356490.ref036","doi-asserted-by":"crossref","first-page":"107652","DOI":"10.1016\/j.cdnut.2026.107652","article-title":"Association of Dietary Patterns with Incident Type 2 Diabetes Among Migrant and Nonmigrant Ghanaian Populations in the Prospective Research on Obesity and Diabetes in African Migrants (RODAM-Pros) Study","volume":"10","author":"LT Appiah","year":"2026","journal-title":"Curr Dev Nutr"},{"issue":"1","key":"pone.0356490.ref037","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41387-018-0029-x","article-title":"Dietary patterns and type 2 diabetes among Ghanaian migrants in Europe and their compatriots in Ghana: the RODAM study","volume":"8","author":"C Galbete","year":"2018","journal-title":"Nutr Diabetes"},{"issue":"10","key":"pone.0356490.ref038","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1249\/MSS.0000000000002357","article-title":"Physical Inactivity among Ghanaians in Ghana and Ghanaian Migrants in Europe","volume":"52","author":"E Afrifa-Anane","year":"2020","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"pone.0356490.ref039","doi-asserted-by":"crossref","first-page":"580","DOI":"10.5551\/jat.65238","article-title":"Harmonization of lipoprotein(a) immunoassays using a serum panel value assigned with the IFCC-endorsed mass spectrometry-based reference measurement procedure as a first step towards apolipoprotein standardization","volume":"32","author":"T Miida","year":"2025","journal-title":"J Atheroscler Thromb"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:32:51Z","timestamp":1787765571000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356490"}},"subtitle":[],"editor":[{"given":"Emmanuel Kwaku","family":"Ofori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0356490","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}